A
Abingworth’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $16.1M | Hold |
1,435,106
| – | – | 5.25% | 6 |
|
|
2022
Q3 | $15.9M | Hold |
1,435,106
| – | – | 5.44% | 6 |
|
|
2022
Q2 | $12.1M | Hold |
1,435,106
| – | – | 3.88% | 6 |
|
|
2022
Q1 | $19.5M | Buy |
1,435,106
+231,971
| +19% | +$3.15M | 5.53% | 6 |
|
|
2021
Q4 | $23.6M | Hold |
1,203,135
| – | – | 5.72% | 6 |
|
|
2021
Q3 | $38.5M | Hold |
1,203,135
| – | – | 8.74% | 5 |
|
|
2021
Q2 | $40.7M | Hold |
1,203,135
| – | – | 12.59% | 2 |
|
|
2021
Q1 | $45.1M | Hold |
1,203,135
| – | – | 15.56% | 2 |
|
|
2020
Q4 | $40M | Hold |
1,203,135
| – | – | 13.67% | 3 |
|
|
2020
Q3 | $44.5M | Hold |
1,203,135
| – | – | 9.52% | 3 |
|
|
2020
Q2 | $39.4M | Hold |
1,203,135
| – | – | 11.01% | 3 |
|
|
2020
Q1 | $30.8M | Hold |
1,203,135
| – | – | 20.47% | 2 |
|
|
2019
Q4 | $37.4M | Buy |
+1,203,135
| New | +$37.4M | 18.09% | 2 |
|